Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov identifier: NCT00730639.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab | Synapse